Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy |
Bhatti, Abu Bakar Hafeez
(Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre)
Khan, Amina Iqbal (Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) Siddiqui, Neelam (Department of Medical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) Muzaffar, Nargis (Department of Medical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) Syed, Aamir Ali (Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) Shah, Mazhar Ali (Department of Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) Jamshed, Arif (Department of Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre) |
1 | Rakha EA, Reis-Filho JS, Ellis IO (2008). Basal-like breast cancer: a critical review. J Clin Oncol, 26, 2568-81. DOI ScienceOn |
2 | Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684-91. DOI ScienceOn |
3 | Wang J, Xie X, Wang X, et al (2013). Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis. Surg Oncol, 22, 247-55. DOI ScienceOn |
4 | Zaky SS, Lund M, May KA, et al (2011). The negative effect of triple-negative breast cancer on outcome after breastconserving therapy. Ann Surg Oncol, 18, 2858-65. DOI |
5 | O'Brien KM, Cole SR, Tse CK, et al (2010). Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res, 16, 6100-10. DOI ScienceOn |
6 | Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. DOI ScienceOn |
7 | Sharif MA, Mamoon N, Mushtaq S, et al (2010). Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan. J Coll Physicians Surg Pak, 20, 181-5. |
8 | Sidoni A, Cavaliere A, Bellezza G, et al (2003). Breast cancer in young women: clinicopathological features and biological specificity. Breast, 12, 247-50. DOI ScienceOn |
9 | Solin LJ, Hwang WT, Vapiwala N(2009). Outcome after breast conservation treatment with radiation for women with triplenegative early-stage invasive breast carcinoma. Clin Breast Cancer, 9, 96-100. DOI ScienceOn |
10 | Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. DOI ScienceOn |
11 | Spitale A, Mazzola P, Soldini D, et al (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20,628-35. DOI ScienceOn |
12 | Van Dongen JA, Voogd AC, Fentiman IS, et al (2000). Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst, 92, 1143-50. DOI ScienceOn |
13 | Li CY, Zhang S, Zhang XB, et al (2013). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. DOI ScienceOn |
14 | Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7. DOI ScienceOn |
15 | Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31. |
16 | Millar EK, Graham PH, O'Toole SA, et al (2009). Prediction of local recurrence, distant metastases, and death after breastconserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol, 28, 4701-8. |
17 | Lowery AJ, Kell MR, Glynn RW, et al (2012). Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat, 133, 831-41. DOI |
18 | Ma KK, Chau WW, Wong CHN, et al (2012). Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14. DOI ScienceOn |
19 | Mersin H, Yildirim E, Berberoglu U, et al (2008). The prognostic importance of triple negative breast carcinoma. Breast, 17, 341-6. DOI ScienceOn |
20 | Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74. DOI ScienceOn |
21 | Chu QD, Henderson AE, Ampil F, et al (2012). Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity. Int J Breast Cancer, 764570. |
22 | Adami HO, Malker B, Holmberg L, et al (1986). The relation between survival and age at diagnosis in breast cancer. N Engl J Med, 315, 559-63. DOI ScienceOn |
23 | Adkins FC, Gonzalez-Angulo AM, Lei X, et al (2011). Triplenegative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol, 18, 3164-73. DOI ScienceOn |
24 | Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34. DOI ScienceOn |
25 | Bauer KR, Brown M, Cress RD, et al (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8. DOI ScienceOn |
26 | Chung M, Chang HR, Bland KI, et al (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103. DOI |
27 | Dawood S, Broglio K, Kau SW, et al (2009). Triple receptornegative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol, 27, 220-6. DOI ScienceOn |
28 | Fisher B, Anderson S, Bryant J, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41. DOI ScienceOn |
29 | Freedman GM, Anderson PR, Li T, et al (2009). Locoregional recurrence of triple-negative breast cancer after breastconserving surgery and radiation. Cancer, 115, 946-51. DOI ScienceOn |
30 | Abdulkarim BS, Cuartero J, Hanson J, et al (2011). Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol, 29, 2852-8. DOI ScienceOn |
31 | Nguyen PL, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol, 26, 2373-8. DOI ScienceOn |
![]() |